Dayama, Porferio L.
HRN: 01-39-51 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2026
CO-AMOXICLAV 625MG (TAB)
08/10/2026
08/17/2026
ORAL
625mg
Every 8hours
Multiple Physical Injuries; Lacerated Wound
Checking Initial Appropriateness